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ABSTRACT 
 
Background: Obesity is one of the global health problems with increasing prevalence, 
and the complication is related to the alteration of the left ventricle. An obese person 
without symptoms has impaired diastolic function compares to a normal population, but 
the mechanism is still unclear. One of the evolving theories is caused by chronic 
inflammation, characterized by the increase of proinflammatory adipocytokines in an 
obese person. Leptin is a chronic inflammatory marker which is synthesized by all 
adipose tissues and has a positive correlation with the body mass index. Leptin level 
are influenced by age except young adult group. The aim of this study is to investigate 
the correlation between leptin level and diastolic function of the left ventricle in young 
adult obese.  
Method: This study was conducted in a single centre with cross-sectional design. The 
subject of this study consists of all young adult obese, worked in Dr. Hasan Sadikin 
General Hospital, between June-August 2018. The diastolic function of the left ventricle 
was measured by examining the ventricle relaxation (E/mean e’) by tissue doppler 
imaging method. The examination of leptin level was done by sandwich-ELISA test 
method. Pearson correlation test was done to assess the correlation between those 
two. 
Result: This study consisted of 38 patients with the mean of age 30.75±7.25 years old, 
68% were males. The mean score of E/mean e’ was 6.49±3.02 ng/mL and the median 
of leptin was 13.95 (9.1–25.4) mg/L. After data log transformation of leptin was done, 
there was a significant positive correlation (r= 0.5892, p<0.001) between leptin level 
and E/mean e’. 
Conclusion: There was a significant correlation between the level of leptin and 
diastolic function of the left ventricle in young adult obese.  
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INTISARI 
 
Latar Belakang: Obesitas merupakan salah satu masalah kesehatan global yang 
prevalensinya terus meningkat, salah satu komplikasinya melibatkan gangguan 
ventrikel kiri. Obesitas yang asimtomatik memiliki fungsi diastolik ventrikel kiri yang 
lebih rendah dibandingkan populasi normal. Mekanisme penurunan fungsi diastolik 
ventrikel kiri tersebut masih belum jelas, namun diketahui disebabkan oleh kondisi 
inflames kronis. yang ditandai dengan peningkatan adipositokin proinflamasi. Leptin 
merupakan adipositokin proinflamasi yang disintesis oleh jaringan adiposa di seluruh 
tubuh dan memiliki korelasi positif dengan indeks massa tubuh. Kadar leptin 
dipengaruhi oleh usia kecuali kelompok usia dewasa muda. Tujuan penelitian ini 
adalah untuk menilai hubungan kadar leptin dan fungsi diastolik ventrikel kiri pada 
obesitas dewasa muda. 
Metode: Penelitian ini merupakan penelitian dengan rancangan potong lintang 
dilakukan pada seluruh obesitas dewasa muda yang bekerja di RSUP Dr. Hasan 
Sadikin Bandung pada bulan Juni-Agustus 2018. Pemeriksaan fungsi diastolik ventrikel 
kiri dilakukan dengan penilaian relaksasi ventrikel kiri yang dinilai dengan E/mean e’ 
dengan teknik tissue doppler imaging. Pengukuran kadar leptin dilakukan dengan 
metode tes sandwich-ELISA. Analisis korelasi Pearson dilakukan untuk menilai 
hubungan antara keduanya. 
Hasil: Penelitian ini melibatkan 38 orang dengan rata-rata usia 30,75 ± 7,25 tahun dan 
68% adalah laki-laki. Rata-rata nilai E/mean e’ adalah 6,49 ± 3,02 ng/mL dan nilai 
median leptin adalah 13,95 (9,1 – 25,4) mg/L. Setelah dilakukan transformasi log pada 
nilai kadar leptin, maka didapatkan uji korelasi positif yang signifikan antara leptin dan 
E/mean e’ (r= 0,5892, p<0,001). 
Kesimpulan: Terdapat hubungan yang signifikan antara kadar leptin dan fungsi 
distolik ventrikel kiri pada populasi obesitas dewasa muda. 
 
 
INTRODUCTION 
 
Obesity is still global health 
problem and incidence continuous to 
increase. The prevalence continues to 
increase in last two decades, with a 
total population of obesity in 2016 is 
650 million, which is around 13% of the 
entire adult population in the world.1,2 
One of obesity complication is related 
to the alteration of the left ventricle.3 
 Obesity causes dysfunction of 
adipose tissue and change in regulation 
to  synthesize and secretion of 
adipocytokines, increased synthesis 
and secretion of proinflammation 
adipocytokines, this condition cause the 
activation of inflammatory signaling 
pathway in the systemic circulation. 
Systemic effects that happen is a 
chronic systemic inflammatory condition 
that can be found in obesity. 
Adipocytokine which has an important 
role in the mechanism of systemic 
inflammatory on obesity among others 
are tumor necrosis factor– alpha (TNF-
α), interleukin-6 (IL-6), C-reactive 
protein (CRP), and leptin. 
Hyperleptinemia is one of the 
conditions that occurred in obesity and 
leptin is the most correlated 
inflammatory marker with BMI 
compared to other inflammatory 
markers.4-12 
 In addition to adipose tissue, 
leptin and its receptor isoforms are 
expressed in various other tissues. 
These include cardiovascular tissues, 
such as endothelial cells,13smooth 
muscle cells,14 and cardiomyocytes.15 
These findings suggest that leptin has 
specific effect on myocardium.16 Leptin 
level are influenced by age except 
young adult group. Considering cardiac 
structure and function, leptin levels 
have been suggested to be associated 
with left ventricular hypertrophy,17 
increased myocardial wall thickness,18 
and impaired cardiac contractile 
function.19 Indeed, elevated  leptin 
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levels have been associated with heart 
failure in patients with both reduced and 
preserved ejection fraction.20-22 Recent 
study showed that high leptin levels are 
independently associated with diastolic 
dysfunction in the general population, 
especially in women.23 
 Thus, leptin exhibits a wide 
range of cardiovascular effects and is 
associated with cardiovascular 
outcome. The association between 
leptin and cardiovascular diseases 
could emerge from direct cellular 
effects in both cardiac and vascular 
tissues. To our knowledge the 
association between leptin levels and 
cardiac structure and function has not 
been studied in young adult obese 
population. Therefore, we tested the 
hypothesis that leptin levels are 
associated with cardiac function in 
patients with obese in young adult 
group. 
 
METHODS 
 
Study population 
 A total of 67 consecutive obese 
person works in Dr. Hasan Sadikin 
General Hospital, Bandung between 
June-August 2018 were included in this 
cross-sectional study. Obese person 
aged between 20-39 years old were 
included in the study, whereas obese 
with diabetes mellitus, hypertension, 
hypertensive heart disease, arrhythmia, 
coronary artery disease, congenital 
heart disease, valvular heart disease, 
all type of cardiomyopathy, pericardial 
disease, myocarditis, heart failure, 
infection, malignancy and poor 
echocardiography window during 
examination were excluded. 
Written informed consent was 
obtained from each subject following a 
detailed explanation of the objective 
and protocol of the study which was 
conducted in accordance with the 
ethical principles stated in the 
“Declaration of Helsinki”, this study was 
approved by the institutional ethic 
committee. 
Leptin measurement and 
echocardiography 
 After fulfilling the inclusion and 
exclusion criteria, subject underwent 
several data collection such as patient 
demographics (age, gender) 
anthropometrics (height, weight, body 
mass index (BMI), upper arm 
circumference). BMI was calculated as 
weight (kg) divided by height squared 
(m2). 
Venous blood samples were 
drawn into EDTA tubes after a 12-h 
overnight fast using standardized 
methods. Plasma leptin levels were 
determined by a commercial enzyme-
linked immunosorbent assay kit 
(BioVendor; Cat No: RD 191001100, 
USA). 
Two-dimensional, M-mode, and 
Doppler echocardiography were 
performed according to the American 
Society of Echocardiography (ASE) 
guidelines by one cardiologist utilising a 
Philips Affiniti 50 ultrasound machine. 
The echocardiographic parameters 
chosen for further study were left 
ventricular mass index (LVMI), left 
ventricular ejection fraction (EF), left 
atrium diameter (LAD), left atrium 
volume index (LAVI) measured by 
dividing LA volume by both body 
surface area (BSA). Tissue Doppler-
derived peak early diastolic septal 
mitral annular velocity (e’), ratio of peak 
early diastolic mitral velocity to tissue 
Doppler-derived peak early diastolic 
mitral annular velocity (E/e’). 
Statistical analysis 
The statistical analysis was 
performed using computer software 
(SPSS version 21.0, SPSS Inc. 
Chicago, IL, USA). For numerical data, 
the data distribution tested using the 
Shapiro-Wilk method. Data that was 
normally distributed in the univariate 
analysis were expressed in mean and 
standard deviation, while data with 
abnormal sample distribution are 
expressed in median with range. 
Bivariate analysis was carried out after 
the univariate analysis to see the 
relationship between two variables. If 
the variables showed normal data 
distribution, then bivariate analysis was 
done using Pearson correlation and if it 
was not normal Spearman rank was 
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used. The p value was less than 0.05 
that considered statistically significant. 
 
RESULT 
 
The study sample comprised 38 
patients (mean (SD) age 31±7 years, 
68% male). Of the total 67 subjects, 29 
patients were excluded because 4 
patients have hypertension, 3 patients 
have diabetes mellitus, 1 patient has 
valvular heart disease, 18 patients with 
poor echocardiography window and 3 
patients refuse to participate. Median 
for BMI was 33.71 (30-43) kg/m2, 
median for upper arm circumference 
was 34 (30-40) cm for men and 36 (30-
45) cm for women. 
Echocardiography parameters 
of the subject are presented in table 1. 
Mean LVEDd in this study was 
50.6±0.51 mm for male and 48.3±0.64 
mm for female, mean LAd in this study 
was 3.55±0.51 mm, mean LVEF was 
67.68±6.26 %. Diastolic function 
parameters were stated in table 1. 
Mean mitral E velocity in this study was 
81.1±26.9 cm/s, mean of mean e’ in 
this study was 11.85±5.15 cm/s.  
Median leptin level in this study was 
13.95 (9.1-25.4) ng/mL. 
Bivariate analysis was 
performed using Spearman rank 
between leptin level and E/mean e’ 
ratio, and resulted with r value =0.598, 
p<0.001 (table 2). The result of 
bivariate analysis showed that there 
was a positive correlation between the 
leptin and E/mean e’. The determinant 
coefficient value R2 was 0.357 which 
meant that the leptin after being 
controlled by confounding can explain 
the variability of diastolic function using 
E/mean e’ ratio by 35%, while the rest 
was influenced by other factors (figure 
1).  
 
DISCUSSION 
 
 In the present study we have 
shown a clear association between 
leptin levels and left ventricular diastolic 
filling in young adult obese population. 
High fasting plasma leptin levels were 
associated with one of markers of 
impaired diastolic function. To our 
knowledge, the association between 
high leptin levels and impaired diastolic 
function has not been previously 
reported in young adult obese 
population. 
We found a correlation between 
leptin and diastolic function with 
exclusion of confounding factors such 
as hypertension, diabetes mellitus, 
coronary artery disease and age 
limitation. These result support previous 
studies about correlation between leptin 
and diastolic function such as Puurunen 
et al.24, Kamimura et al.25, and Fontes-
Carvalho et al.23. 
 Puurunen et al. conducted a 
study in Finland, the study using 
coronary artery disease (CAD) 
population and was divided in 4 
quartiles based on the leptin.24 Based 
on this study elevated plasma leptin 
levels are associated with impaired left 
ventricular diastolic function in patients 
with CAD independently of obesity and 
other confounding variables. Leptin 
may be one of the mechanistic links 
explaining the development of 
congestive heart failure in obese 
subjects.24 
The results in this research 
show that there is a negative correlation 
between leptin levels with left 
ventricular diastolic function using 
E/mean e’ ratio parameter (r=-0.589, 
p<0.001), so it can be concluded that 
the higher levels of leptin will cause the 
higher the parameter of E/mean e’ ratio. 
Results of this study in related with 
other study conducted by the year 2018 
from Kamimura et al.25 in the normal 
population. Kamimura et al. stated that 
increased levels leptin correlated 
negatively with diastolic left ventricular 
function assessed with diastolic wall 
strain (DWS) were examined by 
echocardiography modalities. This 
research suggested that the conditions 
of inflammation has crucial role in 
decreasing function of the myocardium. 
This study could not assess how 
the direction of the relationship of leptin 
and diastolic function parameters of 
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Table 1. Baseline characteristics 
Characteristics 
Total 
n=38 
Age (year), mean±SD 30.75±7.25 
Gender, n (%)  
Male 26 (68) 
Female 12 (32) 
BMI (kg/m
2
), Median(min – max) 33.71 (30-43) 
Upper arm circumference  
Male (cm), Median (Min – Max) 34 (30-40) 
Female (cm), Median (Min – Max) 36 (30-45) 
Echocardiography parameter  
Left atrium diameter (mm), mean ± SD 3.55±0.95 
Left ventricle end diastolic diameter (LVEDd)  
Male (mm), mean±SD 50.60±0.51 
Female (mm), mean±SD 48.30±0.64 
Left ventricle mass index (LVMI)  
Male (g/m
2
), mean±SD 78.21±5.80 
Female (g/m
2
), mean±SD 96.48±7.31 
LVEF (%), mean±SD 67.68±6.26 
Left atrium volume index (ml/m
2
), mean±SD 
Mitral E velocity (cm/s) mean±SD 
17.75±13.15 
81.10±26.90 
Septal e’ (cm/s),mean±SD 10.05±5.95 
Lateral e’ (cm/s),mean±SD 14.70±4.70 
SD=standard deviation ; BMI= body mass index; LVEF=left ventricular ejection fraction 
 
E/mean e’ ratio, namely whether 
leptin's role is as a cause or as a 
marker. Previous theories stated that 
the role of leptin as a cause of 
decreased diastolic left ventricular 
function were: (1) leptin has the effect 
of profibrotic against the heart that can 
increase the levels of collagen in the 
extracellular matrix in muscle cells of 
the heart and the advent of changes in 
the heart muscle cell biology,24 (2) 
leptin can cause interference to 
systems renin-angiotensin-aldosterone, 
renin-angiotensin in disorder-
aldosterone can increase collagen in 
extracellular matrix of the cardiac 
muscle cells effect on increasing the  
rigidity myocyte.26 
Correlation of leptin level and 
left ventricular diastolic function is 
supported by the research of the large 
cohort studies conducted by Fontes-
Carvalho et al.23 asserting that leptin as 
a cause of decreased in left ventricular 
diastolic function based on the results 
of studies which found that higher leptin 
level associated with decreased in 
diastolic function measured by 
echocardiography using Tissue doppler 
imaging (TDI) in follow up for 5 years. 
The association was independent of 
age, gender, ethnicity, systolic blood 
pressure, heart rate, smoking status, 
and BMI. 
 
Table 2. Bivariate analysis 
 
E/mean e’ ratio (average) 
Coefficient R (95% CI)  P value 
Log. Leptin 0.589 (0.332 – 0.765) <0.001 
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Figure 1. Scatter plot showing correlation between leptin and E/mean e’ ratio 
 
The theory of leptin as a cause 
of decreased diastolic left ventricular 
function is also supported by 
experimental studies conducted by Abe 
et al.27 doing the study that states that 
exposure to leptin against the heart 
muscle cells cause changes the 
structure of the heart muscle cells than 
mice without leptin exposure groups. 
The research was also supported by 
Madani et al.28 who conducted research 
on experimental mice with leptin 
exposure in the heart muscle cells 
causes changes in the structure of the 
heart muscle cells than mice without 
the exposure groups leptin. 
There are several limitations in 
this study. Analysis of influence of 
gender between leptin and diastolic 
function cannot be measured due to 
unbalance participant in both groups. 
Due to the design of this study, further 
analysis through a prospective cohort 
study and length of obese is needed to 
explain whether a high leptin is the 
cause of the decrease diastolic 
function. 
 
CONCLUSION 
 There was a significant 
correlation between leptin level and 
diastolic function in young adult obesity. 
The higher leptin level, the lower 
diastolic function. 
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